Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies...
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
The results of two randomized phase 3 trials that investigated the use of laquinimod in patients with relapsing-remitting multiple sclerosis were analyzed using a propensity score model.
The propensity score in each study was defined as the probability of an individual patient being assigned to either the laquinimod or placebo study arm. The ana...
Alternative Titles
Full title
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5027083
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5027083
Other Identifiers
ISSN
1471-2377
E-ISSN
1471-2377
DOI
10.1186/s12883-016-0702-4
